Research Currently Recruiting

The following is a list of research studies currently recruiting patients.

For more information or if you are interested in participating in any of the research studies below, please leave a voicemail for our research team at 206-320-2200.

CONCERTO

A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by an active treatment period, to evaluate the efficacy, safety and tolerability of two doses of oral administration of laquinimod (0.6 mg/day or 1.2 mg/day) in subjects with relapsing remitting multiple sclerosis (RRMS).